LAMEA PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, and Assays), By Application, By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others), By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa PARP Inhibitor Biomarkers Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA PARP Inhibitor Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $33.9 Million by 2031. The Argentina market is showcasing a CAGR of 10.8% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9.5% during (2024 - 2031).

biomarker testing, including it, is increasingly integrated into routine clinical practice across oncology care settings. Healthcare providers recognize the importance of biomarker-guided treatment decisions in optimizing patient outcomes and are incorporating biomarker testing into standard care pathways.

Additionally, Clinical laboratories and molecular diagnostic companies are expanding their testing portfolios to include this, offering healthcare providers access to reliable and comprehensive testing services.

With a higher healthcare budget, Saudi Arabia can invest in expanding its healthcare infrastructure, including hospitals, clinics, and diagnostic facilities. This expansion improves access to healthcare services, including biomarker testing for cancer patients. Increased access to healthcare services leads to higher demand for biomarker testing, including PARP inhibitor biomarkers, thereby driving market growth.

Free Valuable Insights: The Worldwide PARP Inhibitor Biomarkers Market is Projected to reach USD 1.6 Billion by 2031, at a CAGR of 8.3%

Based on Product, the market is segmented into Kits, and Assays. Based on Application, the market is segmented into Breast Cancer, Ovarian Cancer, and Others. Based on Services, the market is segmented into BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Myriad Genetics, Inc.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• NeoGenomics Laboratories
• Qiagen N.V
• Agilent Technologies, Inc.
• Merck KGaA
• Bayer AG
• AstraZeneca PLC
• GlaxoSmithKline PLC (GSK)

LAMEA PARP Inhibitor Biomarkers Market Report Segmentation

By Product

• Kits
• Assays

By Application

• Breast Cancer
• Ovarian Cancer
• Others

By Services

• BRCA 1 & 2 Testing
• HRD Testing
• HRR Testing
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA PARP Inhibitor Biomarkers Market, by Product
1.4.2 LAMEA PARP Inhibitor Biomarkers Market, by Application
1.4.3 LAMEA PARP Inhibitor Biomarkers Market, by Services
1.4.4 LAMEA PARP Inhibitor Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. LAMEA PARP Inhibitor Biomarkers Market by Product
4.1 LAMEA Kits Market by Country
4.2 LAMEA Assays Market by Country

Chapter 5. LAMEA PARP Inhibitor Biomarkers Market by Application
5.1 LAMEA Breast Cancer Market by Country
5.2 LAMEA Ovarian Cancer Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA PARP Inhibitor Biomarkers Market by Services
6.1 LAMEA BRCA 1 & 2 Testing Market by Country
6.2 LAMEA HRD Testing Market by Country
6.3 LAMEA HRR Testing Market by Country
6.4 LAMEA Others Market by Country

Chapter 7. LAMEA PARP Inhibitor Biomarkers Market by Country
7.1 Brazil PARP Inhibitor Biomarkers Market
7.1.1 Brazil PARP Inhibitor Biomarkers Market by Product
7.1.2 Brazil PARP Inhibitor Biomarkers Market by Application
7.1.3 Brazil PARP Inhibitor Biomarkers Market by Services
7.2 Argentina PARP Inhibitor Biomarkers Market
7.2.1 Argentina PARP Inhibitor Biomarkers Market by Product
7.2.2 Argentina PARP Inhibitor Biomarkers Market by Application
7.2.3 Argentina PARP Inhibitor Biomarkers Market by Services
7.3 UAE PARP Inhibitor Biomarkers Market
7.3.1 UAE PARP Inhibitor Biomarkers Market by Product
7.3.2 UAE PARP Inhibitor Biomarkers Market by Application
7.3.3 UAE PARP Inhibitor Biomarkers Market by Services
7.4 Saudi Arabia PARP Inhibitor Biomarkers Market
7.4.1 Saudi Arabia PARP Inhibitor Biomarkers Market by Product
7.4.2 Saudi Arabia PARP Inhibitor Biomarkers Market by Application
7.4.3 Saudi Arabia PARP Inhibitor Biomarkers Market by Services
7.5 South Africa PARP Inhibitor Biomarkers Market
7.5.1 South Africa PARP Inhibitor Biomarkers Market by Product
7.5.2 South Africa PARP Inhibitor Biomarkers Market by Application
7.5.3 South Africa PARP Inhibitor Biomarkers Market by Services
7.6 Nigeria PARP Inhibitor Biomarkers Market
7.6.1 Nigeria PARP Inhibitor Biomarkers Market by Product
7.6.2 Nigeria PARP Inhibitor Biomarkers Market by Application
7.6.3 Nigeria PARP Inhibitor Biomarkers Market by Services
7.7 Rest of LAMEA PARP Inhibitor Biomarkers Market
7.7.1 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product
7.7.2 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application
7.7.3 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services

Chapter 8. Company Profiles
8.1 Myriad Genetics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Neogenomics, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Qiagen N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Merck KGaA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. GlaxoSmithKline PLC (GSK)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 4 LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 5 LAMEA Kits Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Kits Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Assays Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Assays Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 10 LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 11 LAMEA Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 18 LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 19 LAMEA BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 29 Brazil PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 30 Brazil PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 31 Brazil PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 32 Brazil PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 33 Brazil PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 34 Brazil PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 35 Brazil PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 36 Brazil PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 37 Argentina PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 38 Argentina PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 39 Argentina PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 40 Argentina PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 41 Argentina PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 42 Argentina PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 43 Argentina PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 44 Argentina PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 45 UAE PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 46 UAE PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 47 UAE PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 48 UAE PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 49 UAE PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 50 UAE PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 51 UAE PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 52 UAE PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 53 Saudi Arabia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 54 Saudi Arabia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 55 Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 56 Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 57 Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 58 Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 59 Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 60 Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 61 South Africa PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 62 South Africa PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 63 South Africa PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 64 South Africa PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 65 South Africa PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 66 South Africa PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 67 South Africa PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 68 South Africa PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 69 Nigeria PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 70 Nigeria PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 71 Nigeria PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 72 Nigeria PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 73 Nigeria PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 74 Nigeria PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 75 Nigeria PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 76 Nigeria PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 77 Rest of LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 78 Rest of LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 79 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 80 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 81 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 82 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 85 Key Information – Myriad Genetics, Inc.
TABLE 86 Key Information – Thermo Fisher Scientific, Inc.
TABLE 87 key information – Illumina, Inc.
TABLE 88 Key Information – neogenomics, inc.
TABLE 89 Key Information – Qiagen N.V.
TABLE 90 key Information – Agilent Technologies, Inc.
TABLE 91 key Information – Merck KGaA
TABLE 92 Key Information – Bayer AG
TABLE 93 Key Information – AstraZeneca PLC
TABLE 94 Key Information – GlaxoSmithKline PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting PARP Inhibitor Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – PARP Inhibitor Biomarkers Market
FIG 5 LAMEA PARP Inhibitor Biomarkers Market share by Product, 2023
FIG 6 LAMEA PARP Inhibitor Biomarkers Market share by Product, 2031
FIG 7 LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2031, USD Million
FIG 8 LAMEA PARP Inhibitor Biomarkers Market share by Application, 2023
FIG 9 LAMEA PARP Inhibitor Biomarkers Market share by Application, 2031
FIG 10 LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2031, USD Million
FIG 11 LAMEA PARP Inhibitor Biomarkers Market share by Services, 2023
FIG 12 LAMEA PARP Inhibitor Biomarkers Market share by Services, 2031
FIG 13 LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2031, USD Million
FIG 14 LAMEA PARP Inhibitor Biomarkers Market share by Country, 2023
FIG 15 LAMEA PARP Inhibitor Biomarkers Market share by Country, 2031
FIG 16 LAMEA PARP Inhibitor Biomarkers Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 18 Swot Analysis: Illumina, Inc.
FIG 19 Swot Analysis: Qiagen N.V.
FIG 20 Swot Analysis: Agilent Technologies, Inc.
FIG 21 Swot Analysis: Merck KGaA
FIG 22 Swot Analysis: Bayer AG
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 SWOT Analysis: GlaxoSmithKline PLC